BICYCLE THERAPEUTICS PLC (BCYC) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-30

Key Insights

Bicycle Therapeutics announced Q1 2026 financial results on April 30, 2026, indicating the company is actively reporting operational progress and financial performance to shareholders.
The filing is a routine earnings announcement (Item 2.02) with the press release furnished but not filed, meaning it does not have the liability protections of official SEC filings.
The company maintains its listing on NASDAQ under ticker BCYC with both ordinary shares and American Depositary Shares available for trading.

Want the newest filings?

This analysis covers the filing from 2026-04-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-03-17

Bicycle Therapeutics announced the appointment of Jennifer Perry, Pharm.D. as the new Chief Operating Officer, effective March 17, 2026, succeeding Alistair Milnes who will take on the role of Chief Corporate Development Officer.
The company reported its financial results for the fiscal quarter and full year ended December 31, 2025, which will be of interest to investors.
Dr. Perry has over 20 years of experience in the biotech and pharmaceutical industries, including 15 years in oncology, which could provide valuable leadership for the company's development and commercialization efforts.

Filed: 2026-01-12

Bicycle Therapeutics plc issued a press release on January 12, 2026, outlining its recent accomplishments and strategic priorities for the year.
The company's securities, including ordinary shares and American Depositary Shares, are listed on The Nasdaq Stock Market LLC.
Bicycle Therapeutics identifies itself as an emerging growth company, which could provide certain regulatory and financial reporting advantages.

Other reports for BICYCLE THERAPEUTICS PLC

Quarterly Report Insider Trading Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.